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Background and Purpose—Little is known about the association between covert vascular brain injury and cognitive 
impairment in middle-aged populations. We investigated if scores on a cognitive screen were lower in individuals with 
higher cardiovascular risk, and those with covert vascular brain injury.
Methods—Seven thousand five hundred forty-seven adults, aged 35 to 69 years, free of cardiovascular disease underwent 
a cognitive assessment using the Digital Symbol Substitution test and Montreal Cognitive Assessment, and magnetic 
resonance imaging (MRI) to detect covert vascular brain injury (high white matter hyperintensities, lacunar, and nonlacunar 
brain infarctions). Cardiovascular risk factors were quantified using the INTERHEART (A Global Study of Risk Factors 
for Acute Myocardial Infarction) risk score. Multivariable mixed models tested for independent determinants of reduced 
cognitive scores. The population attributable risk of risk factors and MRI vascular brain injury on low cognitive scores 
was calculated.
Results—The mean age of participants was 58 (SD, 9) years; 55% were women. Montreal Cognitive Assessment and Digital 
Symbol Substitution test scores decreased significantly with increasing age (P<0.0001), INTERHEART risk score 
(P<0.0001), and among individuals with high white matter hyperintensities, nonlacunar brain infarction, and individuals 
with 3+ silent brain infarctions. Adjusted for age, sex, education, ethnicity covariates, Digital Symbol Substitution test 
was significantly lowered by 1.0 (95% CI, −1.3 to −0.7) point per 5-point cardiovascular risk score increase, 1.9 (95% 
CI, −3.2 to −0.6) per high white matter hyperintensities, 3.5 (95% CI, −6.4 to −0.7) per nonlacunar stroke, and 6.8 (95% 
CI, −11.5 to −2.2) when 3+ silent brain infarctions were present. No postsecondary education accounted for 15% (95% 
CI, 12–17), moderate and high levels of cardiovascular risk factors accounted for 19% (95% CI, 8–30), and MRI vascular 
brain injury accounted for 10% (95% CI, −3 to 22) of low test scores.
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Silent brain infarctions (SBI), or silent strokes where symp-toms are absent or unrecognized, are subcortical cavities 
(lacunes) or cortical areas of atrophy and gliosis, which are 
presumed to be caused by previous infarction.1 White matter 
hyperintensities (WMHs) are also presumed to be caused by 
brain ischemia.1 Prior epidemiological studies indicate these 
vascular brain injuries are associated with cognitive decline, 
incident stroke, dementia, and death.2–4
The presence of SBI is higher in people with traditional 
cardiovascular risk factors including hypertension, diabetes 
mellitus, smoking, and cholesterol.5–8 These risk factors are 
also associated with increased cognitive decline in older popu-
lations.4 However, the results of clinical trials using medica-
tions to alter cardiovascular risk factors have not consistently 
shown reductions in cognitive decline.9–12
We hypothesized that cardiovascular risk factors and 
silent vascular brain injury, as detected by magnetic reso-
nance imaging (MRI), would be significantly associated with 
reduced cognitive function. Therefore, we investigated if 
scores on 2 tests, a cognitive screen and a test of processing 
speed, are lower in individuals with higher cardiovascular 
risk and those with subclinical vascular brain injury in a large 
population-based sample.
Methods
The authors declare that all supporting data are available within the 
article and the Data Supplement. The CAHHM (Canadian Alliance 
of Healthy Hearts and Minds) is a prospective cohort study where 
the majority of participants (>80%) were recruited through existing 
cohorts as previously described13 (Table I in the Data Supplement). 
Research Ethics Board approval was obtained, and all participants 
provided informed consent. Participants were eligible if they were 
between ages 35 and 69 years at the time of enrollment into their 
parent cohort and willing to have additional questionnaires, phys-
ical measurements, and an MRI scan completed. Participants were 
excluded if they had contraindications to an MRI scan.13 Details 
of the CAHHM MRI protocol have been previously published.8,13 
Nonlab-based INTERHEART (A Global Study of Risk Factors for 
Acute Myocardial Infarction) risk score (IHRS) is a previously vali-
dated score which quantifies cardiovascular risk burden, and shown 
to be incrementally associated with SBI8 and quantified cardiovas-
cular risk factor burden. IHRS includes age, sex, smoking status, 
diabetes mellitus, high blood pressure, family history of myocardial 
infarction, waist-to-hip ratio, home or work stress, depression, simple 
dietary questions, and physical activity.14,15 IHRS scores range from 
0 to 48; low risk is defined as a score of 0 to 9, moderate risk as 10 
to 16, and high risk as 17+. For educational level, participants were 
classified as having high school (or less), trade/technical, college or a 
university earned certificate, bachelor’s degree, or a graduate degree.
Key Brain Injury Measures
Participants underwent a short noncontrast enhanced scan using a 1.5 
Tesla or 3 Tesla magnet.13 Brain infarcts were identified on a high-
resolution 3-dimensional T1-weighted sequence and 2-dimensional 
fluid-attenuated inversion recovery sequence by either magnetic 
Conclusions—Among a middle-aged community-dwelling population, scores on a cognitive screen were lower in individuals 
with higher cardiovascular risk factors or MRI vascular brain injury. Much of the population attributable risk of low 
cognitive scores can be attributed to lower educational attainment, higher cardiovascular risk factors, and MRI vascular 
brain injury.   (Stroke. 2020;51:1158-1165. DOI: 10.1161/STROKEAHA.119.028179.)
Key Words: brain ◼ cardiovascular disease ◼ cognition ◼ infarction ◼ risk factors
Figure 1. Prevalence of silent brain infarctions (SBI) and high white mat-
ter hyperintensity (HWMH) as well as mean scores of Digital Symbol 
Substitution test (DSST) and Montreal Cognitive Assessment (MoCA) in 
the overall study population and by age and sex. Bars represent propor-
tion of participants in age and sex group with (A) SBI or (B) HWMH and 
mean (C) DSST or (D) MoCA scores by age groups and sex. Proportions 
(%) and means presented above bars; counts presented at the bottom. 
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resonance readers or a blinded neuroradiologist or neurologist. Key 
brain injury measures included high WMH (HWMH) burden and 
SBIs. WMH was rated on the Fazekas score, a visual rating scale vali-
dated to correlate with volumetric measurements.16 High was defined 
as Fazekas score ≥4 (summing the periventricular and subcortical 
grades), which indicates beginning confluent or confluent WMH.13 
Infarcts were subcategorized based on location and size as small (≤15 
mm axial diameter) subcortical lacunes, following Standards for 
Reporting Vascular Changes on Neuroimaging,17 versus larger (>15 
mm axial diameter) or cortical infarcts.18 Thalamic infarcts were clas-
sified as lacunar. The number of infarcts was calculated as the sum of 
all infarcts in all locations.
Cognitive Tests
Two measures were used. The Digital Symbol Substitution test 
(DSST) is a 2-minute test requiring participants to match symbols 
with numbers according to a code.19 Potential scores range from 0 to 
133, and lower scores indicate worse performance. The DSST is com-
monly used in large cohorts and clinical trials, owing to its’ ability to 
display age-related effects over the age of 40 to 70 years, predict clin-
ically important events including falls and mortality, language-inde-
pendence and sensitivity to change over time, and mildly impaired 
cognition.9,20 Cutoff values of 1 and 2 SD below the mean DSST are 
commonly used clinical thresholds for mild cognitive impairment 
and to define frank cognitive impairment, respectively. The Montreal 
Cognitive Assessment (MoCA) is a global cognitive screening test21 
taking 10 to 15 minutes to administer and evaluates delayed recall, 
verbal fluency, visuospatial skills, executive functions, calculation, 
abstraction, language, orientation, attention, and concentration.21 
Scores range from 0 to 30, and a score of ≥26 denotes normal cogni-
tive function. Education level was included in all of the score analyses 
as an adjusting factor.
Statistical Analysis
The primary outcomes of DSST and MoCA were analyzed as linear 
continuous variables. Vascular brain injury frequency and cognitive 
function scores were examined by increasing age ranges stratified by 
sex, and P
trend
 was calculated using linear contrasts for continuous 
measures and the Cochran Armitage Test for bivariate measures. 
Generalized linear mixed models with random intercepts for center, 
using an unstructured covariance matrix, were used for the com-
parison of cognitive function scores in participants: (1) categorized 
by their IHRS category, (2) with a normal brain MRI (no SBI) to 
those with SBI subdivided by lacunar and nonlacunar types, and (3) 
with HWMH to those without. Minimally adjusted cognitive scores 
included age, sex, ethnicity, and educational level, and maximally 
adjusted models also included the presence of HWMH (when the 
exposure of interest is SBI), SBI (when HWMH is the exposure of 
interest), and cardiovascular risk factors. Pairwise comparisons were 
calculated by Tukey-Kramer adjusted pairwise comparisons. Linear 
mixed models, with center as a random effect, were constructed to de-
termine the joint effects of HWMH, stroke type, stroke count adjusted 
for age, sex, ethnicity, education level, and the IHRS on the mean 
change in cognitive function score. To aid clinical interpretation, the 
differences in cognitive function scores are also expressed in equiva-
lent years of cognitive aging (derived from the beta coefficient for age 
in the fully adjusted models). The population attributable risk (PAR)22 
of each modifiable factor was calculated using logistic regression, by 
dichotomizing the DSST to <1 SD below the mean, the MoCA score 
to <26, and including center and ethnicity as a fixed effect. The IHRS 
was categorized into low, moderate, or high-risk categories, and ed-
ucation was dichotomized into completed high school or less versus 
any further education. The PAR quantifies the proportion of prevent-
able events if the identified factor(s) were eliminated while other fac-
tors were held unchanged. SAS 9.4 (SAS Institute, Inc, Cary, NC) 
was used for all statistical analyses.
Table 1. Baseline Characteristics by IHRS Category
IHRS Category
 Overall Low Risk (0–9) Moderate Risk (10–16) High Risk (17+) P
Trend
N 7547 3793 2407 1311  
IHRS, mean (SD) 10.1 (5.8) 5.5 (2.6) 12.2 (1.7) 19.4 (3.3)
Age, mean (SD) 57.8 (8.9) 56.0 (8.8) 59.1 (8.9) 60.5 (8.0)  
Female, % 55.3 (4173/7547) 65.4 (2479/3793) 48.8 (1174/2407) 38.4 (503/1311)  
Highest level of education
  High school or less,% 13.2 (971/7382) 10.1 (374/3713) 13.6 (321/2361) 21.2 (270/1274)  
  College or trade, % 31.9 (2355/7382) 28.9 (1073/3713) 33.7 (796/2361) 37.3 (475/1274)  
  Bachelor degree, % 32.7 (2412/7382) 35.7 (1324/3713) 31.8 (750/2361) 25.7 (327/1274)  
  Graduate degree, % 22.3 (1644/7382) 25.4 (942/3713) 20.9 (494/2361) 15.9 (202/1274)  
White, % 80.4 (6064/7545) 78.8 (2989/3791) 80.1 (1928/2407) 85.3 (1118/1311)  
DSST,* mean (SE) 73.9 (72.7 to 75.0) 74.6 (73.4 to 75.9) 73.7 (72.5 to 75.0) 71.9 (70.6 to 73.3) <0.0001
DSST Z,* mean (SE) 0.00 (−0.07 to 0.08) 0.05 (−0.02 to 0.13) −0.01 (−0.09 to 0.07) −0.12 (−0.21 to −0.03) <0.0001
MoCA,* mean (SE) 27.2 (26.9 to 27.5) 27.3 (27.0 to 27.6) 27.2 (26.9 to 27.5) 27.0 (26.7 to 27.4) 0.004
MoCA,* % with score 26+ (SE) 82.5 (78.6 to 85.8) 83.7 (79.9 to 86.9) 82.1 (77.9 to 85.7) 79.4 (74.6 to 83.6) <0.0001
HWMH, % 5.8 (439/7541) 3.7 (142/3790) 6.6 (159/2405) 10.4 (136/1310) <0.0001
Silent brain infarction, % 3.7 (283/7547) 2.5 (94/3793) 4.7 (113/2407) 5.6 (73/1311) <0.0001
  Lacunar, % 2.4 (180/7547) 1.6 (62/3793) 2.7 (66/2407) 3.8% (50/1311)  
  Nonlacunar, % 1.4 (103/7547) 0.8 (32/3793) 2.0 (47/2407) 1.8 (23/1311)  
P
Trend
 calculated using linear contrasts for continuous outcomes and the Cochran Armitage Test for bivariate outcomes. DSST indicates Digital Symbol 
Substitution test; HWMH, high white matter hyperintensity; IHRS, INTERHEART risk score; and MoCA, Montreal Cognitive Assessment.
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Results
Between 2014 and 2018, 7547 participants free of clinical 
stroke or cardiovascular disease completed an MRI scan 
and cognitive tests. Fifty-five percent were women, the 
mean age was 58 years, and 20% were nonwhite. The mean 
MoCA score was 27.1 (SD, 2.3), and the mean DSST was 
73.8 (SD, 15.7).
Age and Sex Distribution of HWMH, SBI, and  
Cognitive Scores
In both women and men with increasing age, the propor-
tion with MRI-detected HWMH and SBI increased signif-
icantly (P
trend
<0.001, Figure 1A and 1B). Conversely, with 
increasing age, DSST and MoCA scores declined signifi-
cantly (P
trend
<0.001, Figure 1C and 1D). Similarly, SBI and 
HWMH increased while DSST and MoCA scores decreased 
across low, moderate, and high IHRS categories (Table 1). 
Specifically, a 5-unit change in IHRS was associated with a 
−0.1 (95% CI, −0.1 to −0.04) reduction in MoCA (equivalent 
to 2.5 years of additional cognitive aging) and a −1.0 (95% 
CI, −1.3 to −0.7) change in DSST (equivalent to 1.4 years of 
cognitive aging).
Cognitive Scores and HWMH
The 5.8% of participants with HWMH were older and had a 
higher burden of cardiovascular risk factors (Table 2). Lower 
scores for both DSST (72.0 [95% CI, 70.3–73.7] versus 74.0 
[95% CI, 72.8–75.1]; P=0.003), equivalent to 2.9 years of 
cognitive aging, and MoCA (27.0 [95% CI, 26.6–27.3] versus 
27.2 [95% CI, 26.9–27.5]; P=0.01), equivalent to 5 years of 
cognitive aging, were observed compared to participants with 
and without HWMH.
Cognitive Scores and SBI
Of 3.7% (283/7547) of participants with SBI, 64% (180/283) 
were lacunar brain infarcts, and 36% (103/283) were nonla-
cunar brain infarcts. Participants with SBI were older and had 
a higher IHRS compared with those with no MRI-detected 
brain infarction. DSST and MoCA scores were not lower in 
participants with lacunar strokes compared with participants 
without SBI: (DSST, 75.0 [95% CI, 72.8–77.3] versus 73.9 
[95% CI, 72.8–75.1]; MoCA: 27.3 [95% CI, 26.9–27.8] versus 
27.2 [95% CI, 26.9–27.5]), whereas DSST and MoCA scores 
were significantly lower among participants with nonlacunar 
stroke (DSST: 68.6 [95% CI, 65.8–71.3]; MoCA: 26.5 [95% 
CI, 26.0–27.1]; Table 2). The DSST and MoCA difference 
Table 2. Cognitive Function Scores by Presence of Silent Vascular Brain Injury





Infarction P Value No HWMH HWMH P Value
N 7264 180 103  7102 439  
Age, mean (SD) 57.6 (8.9) 62.6 (8.5) 63.1 (8.2)  57.3 (8.8) 65.5 (7.0)  
Female, % 55.9 39.4 41.7  55.2 56.7  
Highest level of education
  High school or less, % 13.1 14.3 17.0  12.9 17.3  
  College or trade, % 31.9 30.3 34.0  31.7 35.7  
  Bachelor degree, % 32.8 32.0 25.0  33.0 27.3  
  Graduate degree, % 22.2 23.4 24.0  22.4 19.6  
White, % 80.2 83.9 88.3  79.9 88.2  
IHRS, mean (SD) 10.0 (5.7) 12.1 (6.5) 12.1 (5.6)  9.9 (5.7) 12.6 (6.1)  
Minimally adjusted outcomes (95% CI)
  DSST, mean 73.9 (72.7 to 75.1) 74.5 (72.3 to 76.7) 68.1*† (65.3 to 70.9) <0.0001 74.0 (72.8 to 75.2) 71.6 (69.9 to 73.3) <0.001
  MoCA, mean 27.2 (26.9 to 27.5) 27.3 (26.8 to 27.7) 26.5*† (26.0 to 27.0) 0.003 27.2 (26.9 to 27.5) 26.9 (26.5 to 27.3) 0.003
  MoCA, % with score of 26+ 82.6 (78.7 to 85.9) 80.4 (72.7 to 86.3) 71.0* (60.0 to 80.0) 0.008 82.6 (78.6 to 85.9) 79.0 (73.1 to 84.0) 0.05
Final adjusted outcomes (95% CI)
  DSST, mean 73.9 (72.8 to 75.1) 75.0 (72.8 to 77.3) 68.6*† (65.8 to 71.3) <0.001 74.0 (72.8 to 75.1) 72.0 (70.3 to 73.7) 0.003
  MoCA, mean 27.2 (26.9 to 27.5) 27.3 (26.9 to 27.8) 26.5*† (26.0 to 27.1) 0.005 27.2 (26.9 to 27.5) 27.0 (26.6 to 27.3) 0.01
  MoCA, % with score of 26+ 82.7 (78.8 to 86.0) 81.5 (74.0 to 87.2) 71.8* (60.9 to 80.7) 0.02 82.7 (78.8 to 86.0) 80.2 (74.4 to 85.0) 0.17
Cognitive score estimates minimally adjusted for age, sex, ethnicity, and education, using a random intercept (center) model. Final score estimates adjusted for age, 
sex, ethnicity, education, and IHRS; SBI analysis further adjusted for HWMH and HWMH further adjusted for Brain Infarctions categories. Differences between no stroke 
and lacunar stroke were not statistically significant. DSST indicates Digital Symbol Substitution test; HWMH, high WMH; IHRS, INTERHEART risk score; MoCA, Montreal 
Cognitive Assessment; SBI, silent brain infarction; and WMH, white matter hyperintensity.
Tukey-Kramer adjusted pairwise comparisons:
*P<0.05 between no stroke and nonlacunar stroke.
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was equivalent to 7.6 years and 17 years of cognitive aging, 
respectively.
DSST and MoCA scores were significantly lower in indi-
viduals with more brain infarcts compared to individuals with 
less (P<0.0001) in the maximally adjusted model. Nonlacunar 
infarcts made up >50% of infarcts in participants with 3+ brain 
infarctions (Figure 2). An increase in HWMH frequency from 
5.4% among those with a normal MRI to 28.9% among those 
with 3+ infarcts was observed (P
trend
<0.0001; data not shown). 
In the multivariable cognitive score models, the DSST scores 
were lower by 7.0 (95% CI, −7.4 to −6.7) points for every 
10 years increase in age, by 1.0 (95% CI, −1.3 to −0.7) per 
5-unit change in the IHRS, by 1.9 (95% CI, −3.2 to −0.6) for 
HWMH, by 3.5 (95% CI, −6.4 to −0.7), if a nonlacunar stroke 
was identified, and by 6.8 (95% CI, −11.5 to −2.2) for pres-
ence of 3 + SBI. Conversely, DSST was higher among women 
compared with men with a score increase of 6.5 (95% CI, 
5.9–7.1) and among those with any postsecondary education. 
A similar pattern was observed for MoCA scores (Table 3).
To show the relative importance of modifiable factors as-
sociated with reduced cognitive function from a population 
perspective, the PAR of each modifiable factor (which incor-
porates the frequency of the factor and its strength of asso-
ciation with the outcome) was calculated (1 SD DSST score 
below the mean and MoCA <26, Table 4). PAR estimates show 
the proportion of people with cognitive dysfunction could be 
reduced by 15% (95% CI, 12–17) with increased postsecond-
ary education, by 19% (95% CI, 8–30) if a moderate and high 
level of cardiovascular risk factors were prevented, and by 10% 
(95% CI, −3 to 22) by preventing MRI-detected vascular brain 
injury. MoCA scores showed similar contributions (Table 4).
Discussion
In this large middle-aged population of adults with no prior 
history of cardiovascular disease, MRI-detected covert vas-
cular brain injury was associated with lower scores on a 
cognitive screening test and a neuropsychological test of pro-
cessing speed. These novel findings were especially apparent 
among older-aged individuals with a higher burden of car-
diovascular risk factors, nonlacunar brain infarctions, and 
among those with 3+ SBI of any type. The relationships be-
tween MRI-detected covert vascular brain injury and cogni-
tive scores persist after adjustment for known covariates and 
cardiovascular risk factors. These differences in cognitive 
scores, whereas modest and not of immediate clinical signifi-
cance, could increase the risk for later-life symptomatic cog-
nitive decline if they persist and worsen. Additionally, they 
support a need for good vascular risk factor control in midlife 
to prevent vascular brain injury.
Our large study allowed us to separately identify associa-
tions between infarct subtypes and cognitive scores, whereas 
most prior studies were smaller and by necessity grouped all 
infarcts together.23–25 Interestingly, in our relatively young 
population, the proportion of lacunar to nonlacunar infarcts 
was relatively low (1.75:1) compared with studies of the eld-
erly (13:1).4 We showed that individuals with nonlacunar 
cortical infarcts had lower cognitive scores compared with 
those without. This was not observed for lacunar infarctions. 
Individuals with nonlacunar brain infarction had a 3.5 point 
lower DSST compared with those without, which translates 
into ≈5 years of cognitive aging. Also, an increasing number 
of SBI (of any type, though predominantly nonlacunar) was 
significantly related to reduced cognitive function scores. 
This relationship between cortical infarctions and lower cog-
nition is supported by the Rotterdam study.24 Together with 
prior literature, our findings suggest that infarct type and 
cognition may vary over the life span, with increasing vul-
nerability to small vessel disease (manifest as lacunes) and 
susceptibility to their effects evolving as people transition 
from midlife to older age.
We also observed that HWMH are not benign, as they 
were associated with lower cognitive scores, independent of 
Figure 2. Cognitive function by number of silent brain infarction. Mean 
Digital Symbol Substitution test (DSST) (A) and Montreal Cognitive Assess-
ment (MoCA; B) scores adjusted for age, sex, education, INTERHEART 
risk score, and high white matter hyperintensity by number of silent brain 
infarcts. The grayscale shows the proportion of participants, represented 
by that bar, with no infarcts, lacunar, or nonlacunar infarcts. Note: Although 
participants were between the ages of 35 and 69 y at the time of enroll-
ment, some participants were over the age of 69 y at the time of magnetic 
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SBI and cardiovascular risk factors, in a middle-aged popula-
tion. This is important, given that a previous US study did not 
observe an association between WMH and cognitive func-
tion,26 whereas this association was observed in a smaller yet 
older-aged US cohort,27 the Framingham offspring cohort,28 
and in the PURE MIND study (Prospective Urban Rural 
Epidemiologic MIND Sub-Study).6,29 Our findings are con-
sistent with a recent meta-analysis, showing that HWMH in 
the elderly were associated with an increased risk of future 
stroke 2.4 (95% CI, 1.9–3.8), dementia 1.8 (95% CI, 1.4–
2.4), Alzheimer disease 1.5 (95% CI, 1.2–1.8), and a 2-fold 
increase in death (95% CI, 1.7–2.4).2
The PAR analysis shows the relative contribution of each 
modifiable risk factor for low scores on the DSST and the 
MoCA. Increasingly, PAR is being used to identify the rel-
ative contribution of risk factors for stroke22 and dementia.30 
The impact of educational attainment is substantial and indi-
cates postsecondary education as a potentially modifiable fac-
tor on cognitive health.31 Also, the impact of cardiovascular 
risk factors and vascular brain injury on lowered cognitive 
function occurs partially through the development of SBI and 
HWMH, but not exclusively. This indicates other probable 
pathways by which cardiovascular risk factors are associated 
with cognitive decline.
Our data suggest that prevention and treatment of cardio-
vascular risk factors should reduce vascular brain injury and 
prevent cognitive decline, and it may be reasonable to begin 
such treatment midlife. These findings extend prior work on 
SBI in older populations4 to an earlier stage in the life-course. 
Currently, there are no guidelines for the management of 
asymptomatic MRI-defined SBI or HWMH due to few clinical 
trials which have robustly shown benefit.1 Recently, SPRINT 
Table 3. Multivariable Models of Factors Associated With Cognitive Function Scores
DSST Model MoCA Model
Mean Score Change (95% CI) P Value Mean Score Change (95% CI) P Value
Age (per 10 y) −7.0 (−7.4 to −6.7) <0.0001 −0.4 (−0.4 to −0.3) <0.0001
Female 6.5 (5.9 to 7.1) <0.0001 0.5 (0.4 to 0.6) <0.0001
Highest level of education
  High school or less −6.5 (−7.5 to −5.4) <0.0001 −1.6 (−1.8 to −1.4) <0.0001
  College or trade −4.4 (−5.2 to −3.6)  −1.0 (−1.1 to −0.9)  
  Bachelor degree −1.2 (−2.1 to −0.4)  −0.3 (−0.4 to −0.1)  
  Graduate degree (ref)
IHRS (per 5-unit change) −1.0 (−1.3 to −0.7) <0.0001 −0.1 (−0.1 to −0.0) <0.0001
HWMH −1.9 (−3.2 to −0.6) 0.005 −0.3 (−0.5 to −0.0) 0.03
Nonlacunar stroke −3.5 (−6.4 to −0.7) 0.02 −0.3 (−0.8 to 0.2) 0.22
3+ brain infarctions vs 0−2 brain 
Infarctions
−6.8 (−11.5 to −2.2) 0.004 −1.3 (−2.1 to −0.6) <0.001
DSST indicates Digital Symbol Substitution test; HWMH, high white matter hyperintensity; IHRS, INTERHEART risk score; and MoCA, Montreal 
Cognitive Assessment.
Table 4. Determinants and Their PAR of Reduced Cognitive Function
Odds of DSST <59 (1 SD Below Mean) Odds of MoCA <26
Odds (95% CI) P Value Partial PAR (95% CI) Odds (95% CI) P Value Partial PAR (95% CI)
Age (per 10 y) 2.73 (2.49 to 3.01) <0.0001  1.46 (1.36 to 1.57) <0.0001  
Female 0.41 (0.35 to 0.47) <0.0001  0.76 (0.67 to 0.85) <0.0001  
Any postsecondary education 0.48 (0.40 to 0.58) <0.0001 14.6 (12.1 to 17.1) 0.43 (0.37 to 0.51) <0.0001 14.9 (11.3 to 18.5)
IHRS high risk (score 17+) vs IHRS 
low risk (score 0-9)
1.46 (1.21 to 1.75) <0.0001 19.1 (7.7 to 30.1) 1.44 (1.23 to 1.69) <0.0001 13.8 (5.0 to 22.5)
IHRS moderate risk (score 10-16) vs 
IHRS low risk (score 0-9)
1.19 (1.01 to 1.40) 0.03  1.16 (1.02 to 1.33) 0.03  
HWMH 1.54 (1.21 to 1.95) <0.001 6.7 (2.1 to 11.2) 1.18 (0.94 to 1.48) 0.16 1.6 (−0.8 to 4.0)
Nonlacunar stroke 1.56 (0.91 to 2.62) 0.10 2.1 (−1.8 to 6.0) 1.40 (0.84 to 2.27) 0.18 1.0 (−1.2 to 3.3)
3+ SBI vs less 2.65 (1.18 to 6.05) 0.02 2.3 (−1.5 to 6.2) 2.56 (1.19 to 5.55) 0.02 1.4 (−1.0 to 3.8)
Note: For all PAR models, age, sex, ethnicity, and center are included as fixed effects. For DSST, the partial PAR for the combined Brain Injury variables is 10.0 (−2.7 
to 22.4), Full PAR 92.7 (80.1 to 97.4); for MoCA, the partial PAR for combined Brain Injury variables is 3.6 (−4.0 to 11.1), Full PAR 66.7 (32.6 to 85.4). Postsecondary 
education is defined as obtaining any postsecondary education. DSST indicates Digital Symbol Substitution test; HWMH, high white matter hyperintensities; IHRS, 
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(Systolic Blood Pressure Intervention Trial) blood pressure–
lowering trial showed that intensive compared with standard 
blood pressure management reduced the combined incidence 
of mild cognitive impairment or dementia (hazard ratio, 0.81 
[95% CI, 0.69–0.95]) and was associated with fewer HWMH 
on MRI.10 Additionally, the INFINITY (Intensive Versus 
Standard Blood Pressure Lowering to Prevent Functional 
Decline in Older People) blood pressure–lowering trial 
showed a reduction in HWMH in the intensive compared to 
liberal blood pressure–lowering group.11 These results sup-
port aggressive blood pressure–lowering, although other tri-
als of cardiovascular risk factor modification have shown 
inconsistent benefits.9,12,32 This may be partially due to weak 
effects of risk factor modification over a short time period, 
underpowered studies, the assumption that cardiovascular risk 
effect on cognition occurs through the development of clin-
ical stroke, or not considering the other pathways, including 
HWMH. Future randomized trials targeting one or multiple 
cardiovascular risk factors, or new pathways,33 which incor-
porate a sensitive measure of cognitive function and imaging 
biomarkers, are needed.
Strengths and Limitations
The strengths of CAHHM include: (1) its large size and in-
clusion of a large cohort of middle-aged adults, with suffi-
cient sample size to test associations with infarct location and 
number, (2) all MRIs were performed as per a standardized 
protocol and read in a core lab, and (3) we used the PAR to 
measure the relative contributions of several factors, including 
education and cardiovascular risk factors in addition to MRI 
measures of vascular brain injury. The main limitation is 
the brief cognitive assessment with only a general cognitive 
screen and a neuropsychological test of processing speed, 
which prevents us from making inferences about most cog-
nitive domains and falls short of what is currently considered 
state-of-the-art.34 Another limitation is the cross-sectional 
analysis, in which we are unable to determine the temporal re-
lationship between vascular risk factors, subclinical vascular 
brain injury, and cognition. However, as the MRI findings are 
subclinical, any changes in health behaviors or medication use 
are expected to be minimal, such that the risk factor to cog-
nitive function and brain MRI findings should not be strongly 
influenced by reverse causation.
Conclusions
Scores on a cognitive screen are lower in individuals with 
a higher burden of cardiovascular risk factors, and those 
with MRI-detected vascular brain injury, including HWMH 
and SBI, predominantly the nonlacunar type. Interventions 
designed to optimize modifiable factors, including educa-
tional attainment, cardiovascular risk factors, and covert vas-
cular brain injury, are needed. 
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